In a groundbreaking move, Mexico’s Supreme Court has set a legal precedent that could reshape the country’s drug policy, specifically concerning psilocybin. According to a recent article in Mexico News Daily, the court granted a writ of amparo in April 2021, allowing a select group to use psilocybin for therapeutic purposes. While the ruling is currently limited to the individuals involved in the case, it opens the door for broader legal protections and policy reform. Advocates are now rallying for more inclusive access to psilocybin, fostering dialogue with policymakers and promoting evidence-based discussions. This pivotal decision marks a significant shift in Mexico’s approach to psychedelic substances and could serve as a model for other nations.